[
    [
        {
            "time": "2018-01-02",
            "original_text": "Abbvie settles Humira patent disputes with Novartis unit",
            "features": {
                "keywords": [
                    "Abbvie",
                    "Humira",
                    "patent",
                    "disputes",
                    "Novartis"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Abbvie settles Humira patent disputes with Novartis unit",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "CLASS ACTION UPDATE for ABBV, MGTI and SFIX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",
            "features": {
                "keywords": [
                    "CLASS ACTION",
                    "ABBV",
                    "MGTI",
                    "SFIX",
                    "Levi & Korsinsky"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "legal"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "CLASS ACTION UPDATE for ABBV, MGTI and SFIX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "Sandoz, AbbVie Announce Global Resolution Of Humira Patent Disputes",
            "features": {
                "keywords": [
                    "Sandoz",
                    "AbbVie",
                    "Humira",
                    "patent",
                    "disputes"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Sandoz, AbbVie Announce Global Resolution Of Humira Patent Disputes",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",
            "features": {
                "keywords": [
                    "SHAREHOLDER",
                    "Schall Law Firm",
                    "Class Action",
                    "Lawsuit",
                    "AbbVie"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "legal"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",
                "Correlation": 8,
                "Sentiment": 2,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "AbbVie stock ticks higher as Humira patent dispute with Novartis resolved",
            "features": {
                "keywords": [
                    "AbbVie",
                    "stock",
                    "ticks higher",
                    "Humira",
                    "patent",
                    "dispute",
                    "Novartis"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie stock ticks higher as Humira patent dispute with Novartis resolved",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "Can biotech thrive in a highrise? One developer discovers that it can",
            "features": {
                "keywords": [
                    "biotech",
                    "highrise",
                    "developer"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "real estate",
                    "biotech"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Can biotech thrive in a highrise? One developer discovers that it can",
                "Correlation": 1,
                "Sentiment": 5,
                "Importance": 1,
                "Impact": 1,
                "Duration": 1,
                "Entity_Density": 1,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Sandoz",
            "features": {
                "keywords": [
                    "AbbVie",
                    "HUMIRA",
                    "patent",
                    "disputes",
                    "Sandoz"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Sandoz",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-02",
            "original_text": "SHAREHOLDER ALERT: TRCO USAT MCHP COCP ABBV ALNY MGTI CHGG ADNT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines",
            "features": {
                "keywords": [
                    "SHAREHOLDER ALERT",
                    "TRCO",
                    "USAT",
                    "MCHP",
                    "COCP",
                    "ABBV",
                    "ALNY",
                    "MGTI",
                    "CHGG",
                    "ADNT",
                    "Law Offices",
                    "Vincent Wong",
                    "Class Action"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "legal"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "SHAREHOLDER ALERT: TRCO USAT MCHP COCP ABBV ALNY MGTI CHGG ADNT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-10-12",
            "original_text": "AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2018",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Ex-Dividend",
                    "Date",
                    "Scheduled"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2018",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        }
    ]
]